PTBP3 and gallbladder cancer: Further, we found that PTBP3 promoted immune escape in gallbladder cancer via ΔIL‐18, which decreased FBXO38 transcription levels in CD8+T cells to reduce FBXO38‐mediated degradation of PD‐1.